Tundra Targeted Therapeutics is a guide for patients’ T‑cells to recognize and destroy cancer cells with fewer side effects.
Tundra Targeted Therapeutics has raised $444K in total funding. The most recent round was Undisclosed. The last funding was announced in June 2025.
Tundra Targeted Therapeutics is headquartered in Wisconsin Rapids, United States.
Tundra Targeted Therapeutics is a guide for patients’ T‑cells to recognize and destroy cancer cells with fewer side effects.
Tundra Targeted Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tundra Targeted Therapeutics — Funding & Investors." VCBacked, June 2, 2025, https://www.vcbacked.co/company/tundra-targeted-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Tundra Targeted Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/tundra-targeted-therapeutics
{{cite web |title=Tundra Targeted Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tundra-targeted-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated